SCLP — Scancell Holdings Cashflow Statement
0.000.00%
- £101.18m
- £100.56m
- £4.71m
Annual cashflow statement for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.8 | -3.77 | -14.3 | -9.12 | -15.3 |
Depreciation | |||||
Non-Cash Items | 8.3 | -8.84 | 3.11 | -8.53 | 1.69 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.449 | 1.68 | 2.15 | 1.02 | 6.34 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.8 | -10.2 | -8.14 | -15.7 | -6.4 |
Capital Expenditures | -0.744 | -1.27 | -0.203 | -0.177 | -1.54 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.003 | 0.004 | 0.284 | 0.355 | 0.336 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.741 | -1.26 | 0.081 | 0.178 | -1.2 |
Financing Cash Flow Items | -1.41 | -0.537 | -0.537 | -1.24 | -0.741 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 46.1 | -0.928 | -0.746 | 10.4 | 9.69 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37.5 | -12.4 | -8.8 | -5.1 | 2.08 |